Interview: Medicines for Europe Reports on EU Biosimilar Success

The Center for Biosimilars^® (CfB) spoke with Adrian van den Hoven, Director General of Medicines for Europe, and Diogo Piedade, market access manager for Medicines for Europe, about their scorecard report for biosimilar access in European markets.

IQVIA - Assessing the Biosimilar Void 30 October 2023 While biosimilar competition in Europe has played a vital role…
Market review Biosimilar medicines policy 2023 - Policy… 27 September 2023 The Biosimilar Market Access Committee (Biosimilar medicines Group, a Medicines…
"Central Role For Industry Beckons As Europe Rebuilds After… 25 October 2021 Generics And Biosimilars Must Become A Central Policy Pillar, Says…
Health Policy Watch: Forum Discusses High Drug Prices in… 12 February 2024 Adrian van den Hoven, chair of the International Generic and…

Interview: Medicines for Europe Reports on EU Biosimilar Success

27 July 2020

Related Posts